Cargando…
Allosteric modulation of the GTPase activity of a bacterial LRRK2 homolog by conformation-specific Nanobodies
Mutations in the Parkinson's disease (PD)-associated protein leucine-rich repeat kinase 2 (LRRK2) commonly lead to a reduction of GTPase activity and increase in kinase activity. Therefore, strategies for drug development have mainly been focusing on the design of LRRK2 kinase inhibitors. We re...
Autores principales: | Leemans, Margaux, Galicia, Christian, Deyaert, Egon, Daems, Elise, Krause, Linda, Paesmans, Jone, Pardon, Els, Steyaert, Jan, Kortholt, Arjan, Sobott, Frank, Klostermeier, Dagmar, Versées, Wim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135905/ https://www.ncbi.nlm.nih.gov/pubmed/32167135 http://dx.doi.org/10.1042/BCJ20190843 |
Ejemplares similares
-
Nanobodies as allosteric modulators of Parkinson’s disease–associated LRRK2
por: Singh, Ranjan K., et al.
Publicado: (2022) -
A homologue of the Parkinson’s disease-associated protein LRRK2 undergoes a monomer-dimer transition during GTP turnover
por: Deyaert, Egon, et al.
Publicado: (2017) -
Allosteric inhibition of LRRK2, where are we now
por: Soliman, Ahmed, et al.
Publicado: (2020) -
Roco Proteins: GTPases with a Baroque Structure and Mechanism
por: Wauters, Lina, et al.
Publicado: (2019) -
Structural biology of the LRRK2 GTPase and kinase domains: implications for regulation
por: Gilsbach, Bernd K., et al.
Publicado: (2014)